HArmonyCa Lidocaine

HArmonyCa Lidocaine is a hybrid hyaluronic acid and calcium hydroxyapatite injectable facial implant for the Allergan Aesthetics range, intended for facial soft tissue augmentation. It is suitable for authorised medical practitioners, who place it in the deep dermal and sub-dermal layers of the mid and lower face, where the hyaluronic acid provides an immediate lifting and volumising effect and the calcium hydroxyapatite microspheres support sustained collagen stimulation, so one treatment gives both an instant result and progressive structural support. The product contains calcium hydroxyapatite microspheres of 25 to 45 microns at 55.7%, cross-linked sodium hyaluronate gel at 20 mg/mL, phosphate buffer and lidocaine hydrochloride at 3 mg/mL (0.3%) to reduce pain during treatment, and it is a CE-marked medical device for professional use by authorised medical practitioners only. It is supplied as two 1.25 mL pre-filled glass syringes with two single-use 27G half-inch thin-wall sterile needles.

• Provides an immediate lifting and volumising effect through hyaluronic acid
• Supports sustained collagen stimulation through calcium hydroxyapatite
• Combines hyaluronic acid and calcium hydroxyapatite in one ready-to-use injectable
• Designed for facial soft tissue augmentation in the deep dermal and sub-dermal layers
• Contains 0.3% lidocaine hydrochloride to reduce pain during treatment
• Supplied as two 1.25 mL pre-filled syringes with two 27G thin-wall needles
• CE-marked medical device

适应症与专业用途

主要适应症

• Facial soft tissue augmentation
• Deep dermal and sub-dermal facial volume augmentation

专业用途

For use only by authorised medical practitioners in accordance with local regulation, under sterile conditions, following clinical assessment. Single use, single patient; do not re-sterilise. Insert at approximately 30 degrees into the deep dermis with the bevel oriented downwards, using a linear threading technique, and cross-hatching in layers where larger volumes are required. Aspirate before injecting. Subsequent treatments may be required, with at least seven days between treatments to allow evaluation of the outcome, and at least four weeks between ultrasound-based, laser or peeling treatments and use of this product. It is contraindicated in pregnancy or breastfeeding, in patients under 18, in patients with known sensitivity to any product component or to lidocaine or other amide-type local anaesthetics, and in patients with conditions for which lidocaine is contraindicated. It is also contraindicated in skin disease or abnormal skin conditions, acute or chronic infection or inflammation at or near the treatment site, susceptibility to keloid or hypertrophic scarring, impaired wound healing, prolonged bleeding, a history of anaphylaxis or multiple severe allergies, known sensitivity to steroids, herpes, and autoimmune disease. It must not be injected into the glabellar or periocular areas, the lips or perioral region, regions containing foreign bodies, blood vessels or highly vascularised areas, or the epidermis or superficial dermis.

治疗部位

• Mid and lower face
• Cheek lines
• Lower-face contour and sagginess
• Skin firmness

适用患者

Patients aged 18 years or older who are suitable for facial soft tissue augmentation following clinical assessment by an authorised medical practitioner. Contraindicated during pregnancy and breastfeeding, and in patients meeting the other exclusion criteria, including known sensitivity to any product component or to amide-type local anaesthetics. Safety and efficacy have not been evaluated in diabetic patients, in patients who previously received other filling implants, or in patients with a history of keloid formation, connective tissue disease, active bleeding disorders, active hepatitis, cancer, stroke or myocardial infarction, or on immunosuppressive therapy.

作用原理： HArmonyCa Lidocaine ​

为什么选择在 Allpara 订购

Allpara 提供正品、经过验证的 HARMONYCA 产品，来自经过严格审核的供应商，具备完整的批次可追溯性和专家支持。我们为诊所和医美专业人士提供CE认证产品、从欧盟仓库快速配送至欧盟各地，以及具有竞争力的专业价格。我们关注的是您患者的安全、满意度和效果，并提供专属售后支持，让您安心无忧。

常见问题